C0001527||adipose tissue
C0033607||protease inhibitor
C1963724||ART
C1963724||ART
C3536912||HIV PIs
C0600688||toxicity
C0222331||subcutaneous adipose tissue
C0222331||subcutaneous adipose tissue
C0023787||lipodystrophy
C0021655||insulin resistance
C0033607||PIs
C0222331||subcutaneous adipose tissue
C1963724||ART
C0919936||naive
C1963724||ART
C0033607||PI
C1963724||ART
C0222331||subcutaneous adipose tissue
C1963724||ART
C0919936||naive
C0242481||HIVNAT-019 study
C0019693||HIV-infected
C1963724||ART
C0919936||naive
C0337910||Thai
C0033607||PI
C1963724||ART
C0674432||lopinavir
C0292818||ritonavir
C0286738||saquinavir
C1261322||assessments
C0015663||fasting
C0025519||metabolic
C4288169||substudy
C0222331||subcutaneous adipose tissue
C0005558||biopsies
C0040649||transcriptional
C1514534||protein
C0012929||mitochondrial DNA
C0012929||mitochondrial DNA
C0344441||histological analyses
C0008976||ClinicalTrials.gov registration number: NCT00400738
C0243095||limb fat increased
C0206131||adipocytes
C1444656||indicated
C0206131||adipocyte
C0005558||biopsies
C0007634||cells
C1515670||mRNA expression
C0596843||adipogenesis
C1152862||regulator
C1335238||PPARG
C0012929||mitochondrial DNA
C1417846||NRF1
C1515670||mRNA expression
C1565860||COX2
C0033684||COX4 protein
C1444656||indicated
C0026237||mitochondrial
C0007613||function
C0812230||AKT2
C0035696||mRNA
C1335281||PTPN1
C0035696||mRNA
C0021655||insulin resistance
C0920563||insulin sensitivity
C1829779||homeostasis model assessment
C1829779||HOMA-IR
C0442739||unchanged
C0033607||PI
C1963724||ART
C0222331||subcutaneous adipose tissue
C0600688||toxicity
C0023787||lipodystrophy